2005Xiandai yufang yixueRequires access

STUDY OF THE PHARMACOKINETICS OF DOMESTIC ARIPIPRAZOLE IN HEALTHY VOLUNTEERS.

Qi Yu, Liang Mao-zhi

Open publisher page 0 citations

Abstract

Objective:To determine aripiprazole in human plasma by developing a HPLC-UV method,and study the pharmacokinetics profiles of domestic aripiprazole tablets in healthy volunteers.Methods:The multiple oral doses of domestic aripiprazole were given to 14 healthy volunteers.Aripiprazole concentration in human plasma was determined by HPLC method.The pharmacokinetic parameters of aripiprazole were obtained with statistical analysis by DAS1.0.Result:In this study,the healthy volunteers took aripiprazole for 14 d to achieve steady state,and reached the peak concentration(480.3±126.2)μg·L~(-1) at(4.0±0.9)h after the last administration in steady state.AUC_(0-360h) was(38166.6±13241.2)μg·h·L~(-1),t_(1/2β) was(91.0±21.1h),CL/F was (0.62±0.36)L·h~(-1) and V/F was(60.9±43.7)L.Conclusion:The concentration-time curve of aripiprazole was conformed to a two-compartment open model.And it offered necessary information for clinical use of aripiprazole in Chinese.

About this research paper

What this paper is about

Objective:To determine aripiprazole in human plasma by developing a HPLC-UV method,and study the pharmacokinetics profiles of domestic aripiprazole tablets in healthy volunteers.Methods:The multiple oral doses of domestic aripiprazole were given to 14 healthy volunteers.Aripiprazole concentration in human plasma was determined by HPLC method.The pharmacokinetic parameters of aripiprazole were obtained with statistical analysis by DAS1.0.Result:In this study,the healthy volunteers took aripiprazole for 14 d to achieve steady state,and reached the peak concentration(480.3±126.2)μg·L~(-1) at(4.0±0.9)h after the last administration in steady state.AUC_(0-360h) was(38166.6±13241.2)μg·h·L~(-1),t_(1/2β) was(91.0±21.1h),CL/F was (0.62±0.36)L·h~(-1) and V/F was(60.9±43.7)L.Conclusion:The concentration-time curve of aripiprazole was conformed to a two-compartment open model.And it offered necessary information for clinical use of aripiprazole in Chinese.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To determine aripiprazole in human plasma by developing a HPLC-UV method,and study the pharmacokinetics profiles of domestic aripiprazole tablets in healthy volunteers.Methods:The multiple oral doses of domestic aripiprazole were given to 14 healthy volunteers.Aripiprazole concentration in human plasma was determined by HPLC method.The pharmacokinetic parameters of aripiprazole were obtained with statistical analysis by DAS1.0.Result:In this study,the healthy volunteers took aripiprazole for 14 d to achieve steady state,and reached the peak concentration(480.3±126.2)μg·L~(-1) at(4.0±0.9)h after the last administration in steady state.AUC_(0-360h) was(38166.6±13241.2)μg·h·L~(-1),t_(1/2β) was(91.0±21.1h),CL/F was (0.62±0.36)L·h~(-1) and V/F was(60.9±43.7)L.Conclusion:The concentration-time curve of aripiprazole was conformed to a two-compartment open model.And it offered necessary information for clinical use of aripiprazole in Chinese.

Key concepts: Aripiprazole, Pharmacokinetics, Pharmacology, Plasma concentration, Medicine, Schizophrenia (object-oriented programming), Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
STUDY OF THE PHARMACOKINETICS OF DOMESTIC ARIPIPRAZOLE IN HEALTHY VOLUNTEERS. — Research Paper | ScholarLens